AGER and COVID-19: The aims of this study were to test the prognostic value of RAGE and SARS-CoV-2 nucleocapsid viral antigen, as well as a panel of common thromboinflammatory biomarkers, measured on arrival to the emergency department in patients presenting with symptomatic COVID-19.